Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Bayer to invest in rare type of childhood cancer trial Significant funding will enable CRCTU to deliver a new study arm of an international clinical trial for Rhabdomyosarcoma.
News Almost half of patients with inoperable pancreatic cancer are not prescribed essential medication
News Researchers have demonstrated that the molecular basis of immunological memory in T-Cells is epigenetic priming of immune response genes
Posted 13 September 2021 Scientists discover new pathway that prevents bowel cancer treatment from working Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer.
Posted 26 August 2021 Global COVID-19 surgery study scoops scientific world record A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration - involving over 140,000 patients in 116 countries.
Posted 26 August 2021 New study to test third COVID-19 vaccine for people with weakened immune systems A new clinical trial led by the Universities of Birmingham and Glasgow has launched in the UK to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems.